ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
FDA workshop: Insights on inhaled antifungals and antibacterials
Anti-Gram-negative beta-lactams in jeopardy: The rise of PBP3 mutations
New mechanisms for antibiotic reimbursement in the United States: CMS’s IPPS FY2020 Final Rule
COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii
FDA analysis of 40-years of antibacterial development: Dheman et al.
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
Modeling the value of an effective antibiotic — Megiddo et al.
What does an antibiotic cost to develop? What is it worth? How to afford it?
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet